Articles published by Exagen Inc.
Exagen Inc. to Participate in Fourth Quarter Investor Conferences
November 13, 2024
From Exagen Inc.
Via GlobeNewswire
Tickers
XGN
Exagen Inc. Reports Third Quarter 2024 Results
November 12, 2024
From Exagen Inc.
Via GlobeNewswire
Tickers
XGN
Exagen to Announce Third Quarter 2024 Results on November 12, 2024
October 29, 2024
From Exagen Inc.
Via GlobeNewswire
Tickers
XGN
Exagen Announces Acceptance of Five Abstracts at 2024 American College of Rheumatology Convergence
October 21, 2024
From Exagen Inc.
Via GlobeNewswire
Tickers
XGN
Exagen Inc. to Participate in the 2024 Cantor Global Healthcare Conference
September 04, 2024
From Exagen Inc.
Via GlobeNewswire
Tickers
XGN
Exagen Inc. Reports Strong Second Quarter 2024 Results: Raises Guidance due to Record Performance
August 05, 2024
From Exagen Inc.
Via GlobeNewswire
Tickers
XGN
Exagen Appoints Jeffrey G. Black as New Chief Financial Officer
August 01, 2024
From Exagen Inc.
Via GlobeNewswire
Tickers
XGN
Exagen Announces Campaign for Lupus Awareness Month
May 06, 2024
From Exagen Inc.
Via GlobeNewswire
Tickers
XGN
Exagen Inc. Announces Changes to the Board of Directors
April 26, 2024
From Exagen Inc.
Via GlobeNewswire
Tickers
XGN
Exagen Inc. to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
March 08, 2024
From Exagen Inc.
Via GlobeNewswire
Tickers
XGN
Exagen to Announce Fourth Quarter 2023 and Full-Year Financial Results on March 18, 2024
March 07, 2024
From Exagen Inc.
Via GlobeNewswire
Tickers
XGN
Exagen Inc. to Participate in the 2024 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
January 30, 2024
From Exagen Inc.
Via GlobeNewswire
Tickers
XGN
Exagen Inc. Announces Select Preliminary Full-Year 2023 Results and Reaffirms Guidance
January 07, 2024
From Exagen Inc.
Via GlobeNewswire
Tickers
XGN
Exagen Inc. Reports Strong Third Quarter 2023 Results
November 13, 2023
From Exagen Inc.
Via GlobeNewswire
Tickers
XGN
Exagen Inc. and Johns Hopkins University Announce License Agreement for Novel Patented Lupus Nephritis Biomarkers
November 09, 2023
From Exagen Inc.
Via GlobeNewswire
Tickers
XGN
Exagen Inc. to Participate in the 2023 Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
November 02, 2023
From Exagen Inc.
Via GlobeNewswire
Tickers
XGN
Exagen Announces Acceptance of Multiple Abstracts at ACR 2023 Annual Meeting
September 28, 2023
From Exagen Inc.
Via GlobeNewswire
Tickers
XGN
Exagen Inc. to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference
September 12, 2023
From Exagen Inc.
Via GlobeNewswire
Tickers
XGN
Exagen Inc. Reports Strong Second Quarter 2023 Results
August 07, 2023
From Exagen Inc.
Via GlobeNewswire
Tickers
XGN
Exagen Inc. Appoints Paul Kim to Board of Directors
July 24, 2023
From Exagen Inc.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.